IRulya Therapeutics Inc (IRLA) Stock Price & News

All values in USD	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	-	-	-	-
Cost of goods sold	-	-	-	-
Cost of revenue	-	-	-	-
Research and development expenses	8.08M	12.60M	6.84M	5.46M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	3.28M	3.64M	4.27M	16.63M
Operating expense	11.36M	16.24M	11.11M	22.09M
Total operating expenses	11.36M	16.24M	11.11M	22.09M
Operating income	-11.36M	-16.24M	-11.11M	-22.09M
Other non operating income	191.00K	-17.12M	32.84M	3.78M
EBT including unusual items	-13.49M	-36.31M	30.57M	-75.41M
EBT excluding unusual items	-10.87M	-32.65M	21.88M	-17.72M
Income tax expense	-46.00K	3.15M	-5.34M	75.00K
Effective tax rate	0.34%	-8.66%	-17.46%	-0.10%
Other operating expenses	-	-	-	-
Net income	-13.44M	-39.46M	35.91M	-75.49M
Net profit margin	-	-	-	-
Earnings per share	-50.00	-152.00	57.60	-12.15
Interest and investment income	300.00K	227.00K	160.00K	584.00K
Interest expense	-	-	-	-
Net interest expenses	300.00K	227.00K	160.00K	584.00K
Depreciation and amortization charges	-	-	-	-
EBITDA	-11.33M	-16.20M	-11.08M	-22.05M
Gain or loss from assets sale	-	-	-	-

Ask anything